drugset
drugset / Trial / NCT01875848

Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain

NCT01875848 ↗

Phase 4 Terminated 7 enrolled VA Office of Research and Development
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares buprenorphine/naloxone to opioid dose escalation among patients with poorly controlled non-cancer pain on 30-100 mg daily morphine equivalent opioid dose.

Timeline

Start
2013-12
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —
Subject Naloxone Small molecule — —

Indications

No indication recorded.